Certain novel bridged piperidine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.

 
Web www.patentalert.com

< Glycinamides as factor Xa inhibitors

< Pro 1474 polypeptides

> Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same

> Benzosuberonylpiperdine compounds as analgesics

~ 00291